<?xml version="1.0" encoding="UTF-8"?>
<p>Cytokine-induced apoptosis was assessed by evaluating caspase-3 activity, which is a downstream effector of the apoptotic pathway. Two-day treatment of INS-1E cells with a cytokine cocktail resulted in almost 5-fold increase in caspase-3 activity as compared to the no cytokine-treated cells (
 <xref ref-type="fig" rid="pone.0241349.g001">Fig 1D</xref>); however, this increase in caspase activity was suppressed more than 80% by 10 Î¼M bergenin (
 <xref ref-type="fig" rid="pone.0241349.g001">Fig 1D</xref>). Bergenin also reduced caspase-3 activity in a dose-dependent manner (
 <xref ref-type="fig" rid="pone.0241349.g001">Fig 1D</xref>). This assay demonstrated the role of bergenin in preventing beta cell apoptosis, and subsequent increase in beta cell viability.
</p>
